Effects of oral CYTIDIN-5 -DIPHOSFOCHOLINE on vision function in the amblyopia - ECC06-11

• Conditions: Amblyopia; MedDRA version: 9.1Level: LLTClassification code 10001906Term: Amblyopia

• Registration Number: EUCTR2006-006753-27-IT
• Lead Sponsor: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04-03
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age 3-12 Amblyopia Written informed consent
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients affected by serious disease who are not eligible Use of trial drugs in the last 2 weeks

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Efficacy evaluation of CYTIDIN-5 -DIPHOSFOCHOLINE on vision function in patients affected by amblyopia;Secondary Objective: Safety and efficacy in clinical practice of a food supplement;Primary end point(s): Efficacy in visual acuity as measured by ETDRS scale